Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. NJPS [انترنت]. 31 ديسمبر، 2025 [وثق 14 أبريل، 2026];40(2):251-62. موجود في: https://www.ojshostng.com/index.php/njphysiologicalsciences/article/view/4001